These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 16996816)

  • 1. WATCHMAN: an effective protection against stroke?
    Stöllberger C; Schneider B; Finsterer J
    Am Heart J; 2006 Oct; 152(4):e35; author reply e37-8. PubMed ID: 16996816
    [No Abstract]   [Full Text] [Related]  

  • 2. Medical device regulatory reform: insights from the watchman left atrial appendage closure technology for stroke prophylaxis in atrial fibrillation.
    Cingolani E; Stevens S; Shehata M; Diamond GA; Kaul S
    Arch Intern Med; 2011 Oct; 171(18):1670-2. PubMed ID: 21746999
    [No Abstract]   [Full Text] [Related]  

  • 3. WATCHMAN for stroke prevention: an out-of-date procedure.
    Stöllberger C; Finsterer J
    J Am Coll Cardiol; 2007 Aug; 50(9):914; author reply 914-5. PubMed ID: 17719480
    [No Abstract]   [Full Text] [Related]  

  • 4. The PROTECT AF (WATCHMAN Left Atrial Appendage System for Embolic PROTECTion in Patients with Atrial Fibrillation) trial.
    Fountain RB; Holmes DR; Chandrasekaran K; Packer D; Asirvatham S; Van Tassel R; Turi Z
    Am Heart J; 2006 May; 151(5):956-61. PubMed ID: 16644311
    [No Abstract]   [Full Text] [Related]  

  • 5. WATCHMAN matches warfarin.
    Expert Rev Cardiovasc Ther; 2009 May; 7(5):456. PubMed ID: 19419252
    [No Abstract]   [Full Text] [Related]  

  • 6. Percutaneous left atrial appendage transcatheter occlusion: an effective and safe protection against stroke or embolism?
    Stöllberger C; Finsterer J; Schneider B
    J Cardiovasc Electrophysiol; 2004 Mar; 15(3):373; author reply 373-4. PubMed ID: 15030433
    [No Abstract]   [Full Text] [Related]  

  • 7. Percutaneous transcatheter left atrial appendage exclusion in atrial fibrillation.
    Chiam PT; Ruiz CE
    J Invasive Cardiol; 2008 Apr; 20(4):E109-13. PubMed ID: 18398240
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New device for stroke prevention in atrial fibrillation as an alternative to anticoagulation drugs.
    Lobodzinski SS
    Cardiol J; 2009; 16(4):375-8. PubMed ID: 19653186
    [No Abstract]   [Full Text] [Related]  

  • 9. Watching the watchman.
    Block PC
    J Am Coll Cardiol; 2007 Apr; 49(13):1496-7. PubMed ID: 17397681
    [No Abstract]   [Full Text] [Related]  

  • 10. The WATCHMAN device for stroke prophylaxis in atrial fibrillation: an evolving niche.
    Couch G; Sabir I
    Hosp Pract (1995); 2015; 43(1):13-21. PubMed ID: 25559429
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transcatheter occlusion of the left atrial appendage for stroke prevention.
    Bayard YL; Ostermayer SH; Sievert H
    Expert Rev Cardiovasc Ther; 2005 Nov; 3(6):1003-8. PubMed ID: 16292991
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Left atrial appendage closure for stroke prevention in atrial fibrillation: state of the art and current challenges.
    Syed TM; Halperin JL
    Nat Clin Pract Cardiovasc Med; 2007 Aug; 4(8):428-35. PubMed ID: 17653115
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transcatheter left atrial appendage closure for stroke prevention among atrial fibrillation patients.
    Khattab AA; Meier B
    Expert Rev Cardiovasc Ther; 2012 Jul; 10(7):819-21. PubMed ID: 22908912
    [No Abstract]   [Full Text] [Related]  

  • 14. Stroke prevention by means of left atrial appendage strangulation?
    Stöllberger C; Schneider B; Finsterer J
    J Thorac Cardiovasc Surg; 2010 Sep; 140(3):732. PubMed ID: 20723748
    [No Abstract]   [Full Text] [Related]  

  • 15. [Feasibility of percutaneous exclusion of the left atrial appendage: results of 11 cases].
    Himbert D; Cachier A; Brochet E; Majdoub M; Olivot JM; Lavallée P; Serfaty JM; Amarenco P; Vahanian A
    Arch Mal Coeur Vaiss; 2006 Jun; 99(6):585-92. PubMed ID: 16878719
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Post-mortem analysis of a left atrial appendage occlusion device (PLAATO) in a patient with permanent atrial fibrillation.
    Park JW; Gerk U; Franke RP; Jung F
    Cardiology; 2009; 112(3):205-8. PubMed ID: 18682664
    [No Abstract]   [Full Text] [Related]  

  • 17. Potential applicability and utilization of left atrial appendage occlusion devices in patients with atrial fibrillation.
    Fountain R; Holmes DR; Hodgson PK; Chandrasekaran K; Van Tassel R; Sick P
    Am Heart J; 2006 Oct; 152(4):720-3. PubMed ID: 16996847
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elimination of the left atrial appendage during mitral valve surgery does not prevent stroke or embolism.
    Stöllberger C; Schneider B; Finsterer J
    J Cardiovasc Electrophysiol; 2007 Jul; 18(7):E22; author reply E23. PubMed ID: 17532779
    [No Abstract]   [Full Text] [Related]  

  • 19. Device may reduce stroke risk from chronic atrial fibrillation.
    Mayo Clin Health Lett; 2006 Jan; 24(1):4. PubMed ID: 16468155
    [No Abstract]   [Full Text] [Related]  

  • 20. Left atrial appendage occlusion does not eliminate the need for warfarin.
    Whitlock RP; Healey JS; Connolly SJ
    Circulation; 2009 Nov; 120(19):1927-32; discussion 1932. PubMed ID: 19901203
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.